Literature DB >> 27440963

Controlling Hypertension to Prevent Target Organ Damage: Perspectives from the World Hypertension League President.

Daniel T Lackland1.   

Abstract

The evidence from epidemiological and observational studies over the past five decades consistently identify a significant association of blood pressure level and disease risks for both sexes, all races and cultures, as well as all age groups. The evidence is strong such that clinical guidelines and intervention programs focus on blood pressure management and lower blood pressure levels for primary and secondary stroke prevention supported and promoted by numerous organizations including the World Hypertension League. These comprehensive components of population risk reduction are ideal models for the clinical medicine and population health partnership, and timely for global implementation. The accelerated decline in blood pressure-related outcomes (eg, stroke mortality), which began in the 1970s in the US and Western countries, included models for aggressive detection, treatment and control strategies for hypertension. These strategies can be implemented on a global scale to respond to the global risks from blood pressure, which is developing in the most vulnerable populations.

Entities:  

Keywords:  End-stage Renal Disease; Heart Failure; Hypertension; Stroke

Mesh:

Substances:

Year:  2016        PMID: 27440963      PMCID: PMC4948790          DOI: 10.18865/ed.26.3.267

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  24 in total

1.  Redefining Blood-Pressure Targets--SPRINT Starts the Marathon.

Authors:  Vlado Perkovic; Anthony Rodgers
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

Review 2.  Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2015-07       Impact factor: 4.844

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  2014 dietary salt fact sheet of the World Hypertension League, International Society of Hypertension, Pan American Health Organization technical advisory group on cardiovascular disease prevention through dietary salt reduction, the World Health Organization collaborating centre on population salt reduction, and World Action on Salt & Health.

Authors:  Norm R C Campbell; Daniel T Lackland; Mark L Niebylski
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-29       Impact factor: 3.738

Review 5.  Future goals for the treatment of hypertension in the elderly with reference to STOP-Hypertension, SHEP, and the MRC trial in older adults.

Authors:  L Hansson
Journal:  Am J Hypertens       Date:  1993-03       Impact factor: 2.689

6.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; John K Lin; Gitanjali M Singh; Christopher J Paciorek; Melanie J Cowan; Farshad Farzadfar; Gretchen A Stevens; Stephen S Lim; Leanne M Riley; Majid Ezzati
Journal:  Lancet       Date:  2011-02-03       Impact factor: 79.321

7.  Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low-Resource Settings: A Policy Statement From the World Hypertension League.

Authors:  Xin H Zhang; Liu Lisheng; Norm R C Campbell; Mark L Niebylski; Peter Nilsson; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-08       Impact factor: 3.738

8.  The World Hypertension League challenges hypertension and cardiovascular organizations to develop strategic plans for the prevention and control of hypertension.

Authors:  Norm R C Campbell; Dan T Lackland; Liu Lisheng; Xin-Hua Zhang; Peter M Nilsson; Kimbree A Redburn; Mark L Niebylski
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-10       Impact factor: 3.738

9.  Targeting Multivariable Risks: An Opportunity for Population High Blood Pressure Control.

Authors:  Daniel T Lackland
Journal:  J Am Heart Assoc       Date:  2015-09-21       Impact factor: 5.501

Review 10.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

Authors:  Xinfang Xie; Emily Atkins; Jicheng Lv; Alexander Bennett; Bruce Neal; Toshiharu Ninomiya; Mark Woodward; Stephen MacMahon; Fiona Turnbull; Graham S Hillis; John Chalmers; Jonathan Mant; Abdul Salam; Kazem Rahimi; Vlado Perkovic; Anthony Rodgers
Journal:  Lancet       Date:  2015-11-07       Impact factor: 79.321

View more
  3 in total

1.  Health Inequities in Hypertension and Related Organ Damage.

Authors:  George A Mensah
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

2.  The ratio of monocyte frequency to HDL cholesterol level as a predictor of asymptomatic organ damage in patients with primary hypertension.

Authors:  Emel Aydin; Ihsan Ates; Mehmet Fettah Arikan; Nisbet Yilmaz; Fatih Dede
Journal:  Hypertens Res       Date:  2017-03-09       Impact factor: 3.872

Review 3.  The epidemiology of stroke in Africa: A systematic review of existing methods and new approaches.

Authors:  Mayowa Owolabi; Paul Olowoyo; Femi Popoola; Daniel Lackland; Carolyn Jenkins; Oyedunni Arulogun; Rufus Akinyemi; Odunayo Akinyemi; Onoja Akpa; Olanrewaju Olaniyan; Ezinne Uvere; Issa Kehinde; Anbesaw Selassie; Mulugeta Gebregziabher; Raelle Tagge; Bruce Ovbiagele
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-11       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.